Note: Ingredients listed on restricted chemical lists
EC/CAS
59-50-7
Name of the chemical
Chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol
Concentration
100%
General Information
Revision date
2017-05-21
Product name
IMPROVEST Injection * Improvac * Gonadotropin Releasing Factor Analog - Diphtheria Toxoid
1.2.1 Relevant identified uses
Veterinary product
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Zoetis Inc
e-mail address of the competent person responsible for the Safety Data Sheet
VMIPSrecords@zoetis.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H360
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified
Health hazards
Sensitization, skin Category 1 Reproductive toxicity Category 1B
Environmental hazards
Not classified
Signal word
Danger
Hazard statements
May cause an allergic skin reaction. May damage fertility or the unborn child.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Avoid breathing mist or vapor. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If exposed or concerned Get medical advice/attention. If on skin Wash with plenty of water. If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise None known. classified (HNOC)
Additional information
In the event of systemic exposure, this material may cause immune system reactions in humans. Systemic exposure may affect reproductive hormone regulation and thus affect fertility and maintenance of pregnancy. Pregnant women should not administer this product. Women and men of childbearing age should exercise extreme caution when handling this product. Improvest mode of action is immunological like a vaccine. The first exposure either by self injection or needle stick may prime the immune system. The risk of a physiological effect is greater after a second or subsequent injection than after a first. After self injection or needle stick injury do not administer the product, and/or any other product with similar action, in the future.
2.1 Classification of the substance or mixture
Not classified. Health hazards Sensitization, skin Category 1 Reproductive toxicity Category 1B Environmental hazards Not classified. OSHA defined hazards Not classified.
